Previous Close | 5,980.00 |
Open | 5,962.00 |
Bid | 5,954.00 x 0 |
Ask | 5,987.00 x 0 |
Day's Range | 5,938.00 - 6,027.00 |
52 Week Range | 4,476.00 - 7,065.00 |
Volume | |
Avg. Volume | 1,064,793 |
Market Cap | 1.188T |
Beta (5Y Monthly) | 0.97 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -75.95 |
Earnings Date | Nov 06, 2024 |
Forward Dividend & Yield | 104.00 (1.74%) |
Ex-Dividend Date | Mar 28, 2024 |
1y Target Est | 6,066.70 |
High blood pressure is often managed through at-home self-monitoring, a routine which can be difficult to manage for patients with hectic lifestyles. Now, Japanese medtech giant Omron may have the solution.
Omron (OMRNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.